Roth Capital Keeps Prima BioMed (PBMD) at 'Buy' Following Receipt of IMP731-Related European Patent
Go back to Roth Capital Keeps Prima BioMed (PBMD) at 'Buy' Following Receipt of IMP731-Related European Patent| PRIMA BIOMED SP ADR (NASDAQ: PBMD) | Delayed: 1.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $1.54 | |||
| Open | $31.25 | 52 Week Low | $0.72 | |||
| Day High | $1.71 | P/E | N/A | |||
| Day Low | $1.71 | EPS | $0.00 | |||
| Volume | 34,538 | |||||
